Spero Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
3.14 | 61.47 | -94.9% | -3.75 | -183.58% |
| P/S |
|
0.7395 | 33.58 | -97.8% |
|
|
| P/BV |
|
0.6692 | 4.79 | -86.04% |
|
|
| P/FCF |
|
-2.05 | 60.06 | -103.41% |
|
|
| Ev/Ebitda |
|
0.0371 | -17.26 | -100.21% |
|
|
| Ev/S |
|
0.0077 | 22.49 | -99.97% |
|
|
| Ev/FCF |
|
-0.0226 | 67.63 | -100.03% |
|
|
| E/P |
|
0.3379 | 0.0168 | 1906.28% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
20.79 | -12.31 | -268.93% | -273.22 | -107.61% |
| ROE |
|
21.34 | 9.39 | 127.18% |
|
|
| ROA |
|
12.5 | 0.1519 | 8130.39% |
|
|
| ROIC |
|
-101.05 | 7.63 | -1423.62% |
|
|
| ROS |
|
23.58 | -25.64 | -191.96% |
|
|
| ROCE |
|
18.47 | 14.76 | 25.15% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.2757 | -3.68 | -107.49% | 0.105 | +162.44% |
| Nеt Debt/Ebitda |
|
-3.52 | -4.07 | -13.43% |
|
|
| Debt/Ratio |
|
0.0304 | 0.199 | -84.73% |
|
|
| Debt/Equity |
|
0.0508 | 1.67 | -96.95% |
|
|
| Debt/Net Income |
|
0.2431 | 10.34 | -97.65% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1958.19 | 76.2 | 2469.8% | ||
| Growth impulse Ebitda in 5 years |
|
-140.78 | 44.75 | -414.59% | ||
| Growth impulse Net Income in 5 years |
|
-139.39 | -15.36 | 807.49% | ||
| Growth impulse FCF in 5 years |
|
-34.4 | -9.39 | 266.35% | ||
| Growth impulse EPS in 5 years |
|
-113.49 | -84.03 | 35.06% |
IP Score
5.43/10
